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Interleukin-6 and 
protein breakdown in 
hemodialysis
Uremia is associated with negative nitro-
gen balance due to increased catabolism 
of proteins. However, during hemodi-
alysis, the quanity of albumin or other 
synthesized proteins often increases. This 
increased demand for amino acids dur-
ing albumin synthesis could stimulate 
muscle protein breakdown. It has been 
postulated that infusions of amino acids 
during dialysis might ameliorate this 
breakdown. As they report in this issue, 
Raj et al. measured muscle protein and 
the fractional synthesis rates of albumin 
in patients with end-stage renal disease 
before and during hemodialysis without 
or with amino acid infusion. They found 
an increase in albumin synthesis when 
amino acids were infused during hemodi-
alysis (Figure). However, muscle proteoly-
sis increased during hemodialysis, which 
was not aﬀected by the infusion of amino 
acids. When the authors conducted arterio-
venous ﬂux studies on muscles, a net eﬄux 
of interleukin-6 (IL-6) occurred from the 
muscle into the vein. Since IL-6 is known 
to aﬀect protein synthesis (although this 
eﬀect seems to diﬀer in the liver and the 
muscle), these results demonstrate a direct 
correlation between IL-6 eﬄux and mus-
cle breakdown. See page 1054.
Pyrophosphate 
and tissue alkaline 
phosphatase in 
uremic calcification
Medial vascular calciﬁcation is emerg-
ing as a critical phenomenon in renal 
failure that may mediate morbidity. 
The mechanisms controlling tissue cal-
ciﬁcation are complex and involve not 
only changes in the ionic composition 
of the local environment but a number 
of complex cellular changes that medi-
ate the deposition of calcium phos-
phate salts. Among these ionic species, 
pyrophosphate is well known to inhibit 
calciﬁcation. Pyrophosphate is rapidly 
hydrolyzed in the local environment by 
tissue-nonspeciﬁc alkaline phosphatase 
(TNAP). In a new study, Lomashvili et 
al. measured TNAP activity in aortic 
tissue in rats with experimental renal 
failure. The hydrolysis of pyrophos-
phate increased when renal failure was 
induced (Figure), and TNAP protein 
abundance doubled without a concomi-
tant increase in its mRNA expression. 
Mice lacking TNAP still had increased 
TNAP-like activity, though to a lesser 
extent than wild-type mice. Remarkably, 
uremic plasma increased TNAP activ-
ity, suggesting that the activity of this 
enzyme may be under the control of a 
circulating factor. Although the results 
are too preliminary to be conclusive, 
the idea that TNAP activity could be 
‘regulated’ suggests that it might be a 
useful target for therapeutic interven-
tion. See page 1024.
A simple method 
for measurement of 
vascular access blood 
flow
Vascular access flow rate is a neces-
sary component of the assessment and 
estimation of hemodialysis prescrip-
tion in patients on hemodialysis, at 
least in industrialized countries where 
it requires the use of an ultrasound 
device. Tiranathanagul et al. devised 
a technique using the physiological 
principles of dye dilution and used it to 
estimate the flow in vascular access in 
30 patients on hemodialysis by measur-
ing their hematocrit and hemoglobin in 
various parts of the flow circuit (Fig-
ure). The results showed an excellent 
correlation between the new dilution 
method of estimating vascular access 
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